According to a new report, published by KBV research, The Global Prosthetic Heart Valve Market size is expected to reach $13.3 billion by 2028, rising at a market growth of 10.7% CAGR during the forecast period.
The Ambulatory Surgical Centers & Others segment is showcasing a CAGR of 13.8% during (2022 - 2028). The demand for ambulatory surgical clinics significantly increased during the outbreak of the COVID-19 pandemic. Due to increasing workloads in hospitals and other healthcare facilities along with a considerable outburst of a number of patients, the popularity and adoption of ambulatory clinical settings surged.
The Transcatheter segment is leading the Global Prosthetic Heart Valve Market by Product in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $7.56 billion by 2028. The rapidly rising growth of the segment is attributed to the rise in the number of people needing cardiac valve replacement due to the increasing prevalence of cardiovascular diseases all over the world. The patient does not have a long incision that could become infected because the surgical team does not have to open up the complete chest to install the new valve.
The North America market dominated the Global Prosthetic Heart Valve Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $4,862.8 million by 2028. The Asia Pacific market is estimated to witness a CAGR of 11.2% during (2022 - 2028). Additionally, The Europe market would experience a CAGR of 10.5% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/prosthetic-heart-valve-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Meril Life Science Private Limited, Colibri Heart Valve LLC, Artivion, Inc., TTK Healthcare Limited, Edwards Lifesciences Corporation, JenaValve Technology, Inc., and Micro Interventional Devices, Inc.
By End User
By Product
By Geography
Companies Profiled
Unique Offerings 
